Concepedia

Author

F. C. Breedveld

Leiden University

Also Known As

F Breedveld, F C BREEDVELD, F C BreedveLd, F C Breedveld, F. Breedveld, F. C BREEDVELD, F. C. BREEDVELD, F. C. Breedveld, F.C Breedveld, F.C. Breedveld

142

Publications

14K

Citations

58

H-Index

95

Concepts

All Affiliations

Leiden UniversityLeiden University Medical CenterAmsterdam UMC Location Vrije Universiteit AmsterdamMedical University of Vienna
FC

About

F. C. Breedveld is an author at Leiden University specializing in medicine, rheumatology, and rheumatoid arthritis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

25

36

4.7K

2

Allergy

4

4

144

3

Public Health

3

3

531

4

Health Sciences

2

2

74

5

Biostatistics

1

1

21

F. C. Breedveld

×

101

Publications

13.8K

Citations

57

H-Index

YearCitations

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis

Michael J. Elliott, Ravinder N. Maini, Marc Feldmann,

The Lancet

1994

1.7K

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial

Y P M Goekoop-Ruiterman, Jeska K de Vries‐Bouwstra, Cornelia F Allaart,

Arthritis & Rheumatism

2005

1.4K

EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

Bernard Combe, R. B. M. Landewé, Cédric Lukas,

Annals of the Rheumatic Diseases

2006

792

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

Daniel E. Fürst, Edward Keystone, Jürgen Braun,

Annals of the Rheumatic Diseases

2011

691

Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: A prospective cohort study

F. van Gaalen, Suzanne P. Linn-Rasker, W J van Venrooij,

Arthritis & Rheumatism

2004

636

Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.

P. Charles, M. J. Elliott, Diana Davis,

PubMed

1999

533

Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: A detailed subanalysis of data from the anti–tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study

Josef S Smolen, Chenglong Han, M Bala,

Arthritis & Rheumatism

2005

455

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

Josef S Smolen, R. B. M. Landewé, F. C. Breedveld,

Annals of the Rheumatic Diseases

2010

410

Infliximab in active early rheumatoid arthritis

F. C. Breedveld, P Emery, Edward Keystone,

Annals of the Rheumatic Diseases

2004

236

Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2

Peter Brooks, Paul Emery, Jilly F. Evans,

Lara D. Veeken

1999

222

Page 1